Prognostic significance of metastatic lymph node size in patients with gastric cancer

2003 ◽  
Vol 90 (12) ◽  
pp. 1522-1530 ◽  
Author(s):  
D. K. Dhar ◽  
H. Kubota ◽  
N. Kinukawa ◽  
R. Maruyama ◽  
I. D. Kyriazanos ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Metastatic Lymph Node ◽  
Prognostic Significance ◽  
Metastatic Lymph ◽  
Lymph Node Size ◽  
Node Size

Prognostic significance of the metastatic lymph node ratio compared to the TNM classification in stage III gastric cancer

2021 ◽  
Vol 24 (11) ◽  
pp. 1602
Author(s):  
S Gulmez ◽  
AS Senger ◽  
O Uzun ◽  
S Omeroglu ◽  
C Ofluoglu ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Lymph Node Ratio ◽  
Metastatic Lymph Node ◽  
Tnm Classification ◽  
Prognostic Significance ◽  
Stage Iii ◽  
Metastatic Lymph ◽  
Node Ratio

Prognostic Significance of the Metastatic Lymph Node Ratio in Gastric Cancer Patients

2009 ◽  
Vol 33 (11) ◽  
pp. 2378-2382 ◽  
Author(s):  
Naoto Fukuda ◽  
Yasuyuki Sugiyama ◽  
Akira Midorikawa ◽  
Hiroyuki Mushiake
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Cancer Patients ◽  
Lymph Node Ratio ◽  
Metastatic Lymph Node ◽  
Prognostic Significance ◽  
Metastatic Lymph ◽  
Node Ratio ◽  
Gastric Cancer Patients

Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy

2019 ◽  
Vol 42 (4) ◽  
pp. 209-216 ◽  
Author(s):  
Ahmet Bilici ◽  
Fatih Selcukbiricik ◽  
Mesut Seker ◽  
Basak B. Oven ◽  
Omer Fatih Olmez ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Lymph Node Ratio ◽  
Metastatic Lymph Node ◽  
Prognostic Significance ◽  
Curative Gastrectomy ◽  
Metastatic Lymph ◽  
Node Ratio

scholarly journals Prognostic Significance of Metastatic Lymph Node Ratio in Gastric Cancer

2019 ◽  
Vol 04 (11) ◽  
pp. 787-792
Author(s):  
Aysha Femy ◽  
Anuradha C.K.Rao
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Lymph Node Ratio ◽  
Metastatic Lymph Node ◽  
Prognostic Significance ◽  
Metastatic Lymph ◽  
Node Ratio

Large Metastatic Lymph Node Size, Especially More Than 2 cm: Independent Predictor of Poor Prognosis in Node-Positive Gastric Carcinoma

2007 ◽  
Vol 32 (2) ◽  
pp. 262-266 ◽  
Author(s):  
O. Cheong ◽  
S. T. Oh ◽  
B. S. Kim ◽  
J. H. Yook ◽  
J. H. Kim ◽  
...  
Keyword(s):  
Lymph Node ◽  
Gastric Carcinoma ◽  
Poor Prognosis ◽  
Independent Predictor ◽  
Metastatic Lymph Node ◽  
Node Positive ◽  
Metastatic Lymph ◽  
Lymph Node Size ◽  
Node Size

Prognostic value of metastatic tumoral caveolin-1 expression in patients with resected gastric cancer.

2017 ◽  
Vol 35 (4_suppl) ◽  
pp. 83-83
Author(s):  
Der Sheng Sun ◽  
Soon Auck Hong ◽  
Han Hong Lee ◽  
Hye Sung Won ◽  
Yoon Ho Ko
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Clinical Outcomes ◽  
Metastatic Lymph Node ◽  
Prognostic Significance ◽  
High Expression ◽  
Clinicopathological Parameters ◽  
Cancer Specific Survival ◽  
Caveolin 1 ◽  
Metastatic Lymph

83 Background: Caveolin-1 (Cav-1), as the main component of caveolae, has complex roles in tumourigenesis and clinical outcomes in a variety of human malignancies. We investigated Cav-1 in primary and metastatic tumor of gastric cancer (GC) and its association with clinical outcomes. Methods: All specimens evaluated were obtained from 145 patients with GC who had undergone curative gastrectomy. The primary outcomes measured were the expression levels of Cav-1 by immunohistochemistry and its association with clinicopathological parameters and patient survival. Results: Among the 145 patients, the frequency of high expression of stromal Cav-1 within primary tumor and tumoral Cav-1 protein in metastatic lymph node were 22.5% (18/145) and 16.6% (15/91). In the multivariate analysis tumoral Cav-1 protein in metastatic lymph node showed prognostic significance for relapse-free survival (RFS, HR, 3.934; 95% CI, 1.882–8.224; P < 0.001) and cancer-specific survival outcome (CSS, HR, 3.985; 95% CI, 1.620 – 8.623; P = 0.002). In addition, it remained as a strong indicator of poor prognosis for RFS (HR, 3.137; 95% CI, 1.445 – 6.810; P = 0.004) and CSS (HR, 2.509; 95% CI, 1.079 – 5.838; P = 0.033). Conclusions: High expression of tumoral Cav-1 protein in metastatic lymph node shows a strong negative association with the clinical outcomes in patients with curatively resected GC, suggesting that this protein have potential uses as novel prognostic markers.

Prognostic Significance of the Metastatic Lymph Node Ratio in Patients with Gastric Cancer

2012 ◽  
Vol 36 (5) ◽  
pp. 1096-1101 ◽  
Author(s):  
Sung Ryol Lee ◽  
Hyung Ook Kim ◽  
Byung Ho Son ◽  
Jun Ho Shin ◽  
Chang Hak Yoo
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Lymph Node Ratio ◽  
Metastatic Lymph Node ◽  
Prognostic Significance ◽  
Metastatic Lymph ◽  
Node Ratio

scholarly journals Prognostic Significance of Metastatic Lymph Node Ratio in Patients with Gastric Cancer, an Evaluation in North-East of Iran

2014 ◽  
Vol 25 ◽  
pp. iv227
Author(s):  
A. Taghizadeh Kermani ◽  
S.Z. Yahouyan ◽  
M. Ali Akbarian ◽  
M. Seilanian Tousi ◽  
P. Izadpanahi
Keyword(s):  
Gastric Cancer ◽  
Lymph Node ◽  
Lymph Node Ratio ◽  
Metastatic Lymph Node ◽  
Prognostic Significance ◽  
North East ◽  
Metastatic Lymph ◽  
East Of Iran ◽  
Node Ratio

The Impact of Metastatic Lymph Node Size on Long-term Outcomes for pStage III Colon Cancer

2022 ◽  
Vol 2 (1) ◽  
pp. 31-37
Author(s):  
CHIKARA MAEDA ◽  
YUSUKE YAMAOKA ◽  
AKIO SHIOMI ◽  
HIROYASU KAGAWA ◽  
HITOSHI HINO ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Lymph Node ◽  
Metastatic Lymph Node ◽  
Long Term Outcomes ◽  
Metastatic Lymph ◽  
Lymph Node Size ◽  
The Impact ◽  
Group D ◽  
Node Size

Aim: To clarify the impact of metastatic lymph node size on long-term outcomes in patients undergoing curative colectomy for pathological stage III colon cancer. Patients and Methods: This study enrolled patients who underwent curative colectomy for pStage III colon cancer between January 2013 and December 2015. All patients were divided into four groups based on the short-axis diameter of the largest MLN: Group A, <5 mm; Group B, ≥5 mm and <10 mm; Group C, ≥10 mm and <15 mm; Group D, ≥15 mm. Results: A total of 209 patients were analyzed. The 5-year recurrence-free survival rates of Groups A, B, C, and D were 82.3%, 74.6%, 74.5% and 60.7%, respectively. In multivariate analysis, Group D (hazard ratio=3.95; 95% confidence interval, 1.34-11.65; p=0.01) was independently associated with worse RFS. Conclusion: Bulky MLNs might be a poor prognostic factor in node-positive colon cancer.

Sign in / Sign up

Export Citation Format

Share Document